Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PETX Approval
Up 7% in pre. Was at $8 on partnership news a few weeks ago. Hope to trade out of this one today.
VRX The Street consensus PT is $63.88
"As Valeant milks in from its acquisitions, FY16 revenues are expected to clock in at $10.93billion while $11.82 billion in FY17 (8.4% YoY rise).
The Street consensus PT is $63.88, signaling 96% upside potential. Out of total analysts rating VRX stock, three consider it a Strong Buy, two rate it a Buy, 10 suggest a Hold, four consider the stock an Underperform while one suggests a Sell."
Trade Alert VRX
Purchased 150sh @ $31.89
A lot of bad press on drug pricing and heavy debt load has killed the price since late last year. New CEO as of today - some good press could send this stock higher. 52 week high $263
Ackman said Valeant the “cheapest large company I’ve seen in my career.”
Trade Alert CHK
Sold 600sh @ $6.44. Will look to get back in in the $5 range
Trade Alert SWN
Sold 100sh @ $12.65 for a small loss - freeing up some cash
Trade Alert ONTY
Sold 1000sh @ $1.32
Freeing up cash on a non-marginable security. Will look to buy back soon...
PETX NEWS $8.00
"Under terms of the deal, Elanco will have global exclusive rights to develop, market and commercialize Galliprant while they help co-promote Galliprant in the U.S. with Aratana. For these rights, Aratana will receive an upfront payment of $45 million, with $83 million available in achievement of various milestones.
Aratana Therapeutics CEO Dr. Steven St. Peter said, "We believe that this collaboration with Elanco, a leading animal health company, is a watershed event for the emerging pet biotech sector and further validates our focus on the pet therapeutics opportunity."
At a market cap of $259 million, the $45 million deal equates to roughly ~17 percent the size of Aratana. Shares resumed at 4:35 p.m. ET and immediately spiked a high of $8.78. At the time of publication, shares were up 13 percent to $7.81"
Trade Alert SRPT
Stopped out @ $12.50 - 50sh this morning.
Falling knife.... Lesson learned.
Trade Alert SRPT
Purchased 50sh @ $13.75
FDA docs out - down $6. Just trying to play a bounce here.
Trade Alert PETX Late Post
Purchased 200sh @ $6.55 on 4/15
Have 400sh total now
Trade Alert CHMA Late Post
Sold 25sh @ $4.00 on 4/18
This was my lotto play holding through FDA decision...
Trade Alert CERU
Purchased 600sh @ $3.55 on good trial results
Holding 1000sh total
Trade Alert ONTY
Sold 1000sh @ $1.25 earlier this morning.
Freeing up cash to buy more CERU
CHMA gets CRL
FDA requests new trial with control arm.
Held 25sh through as lotto play. Will sell today for a small loss - solid gains on the 275sh I sold over the past week.
Trade Alert CHMA
Sold 25sh @ $10.58
Limiting my risk on FDA response. Will hold 25sh as lotto play.
News CHK $3.92
"April 11 (Reuters) - Chesapeake Energy Corp said its borrowing base was reaffirmed at $4 billion, but the company had to pledge additional assets as collateral.
Every six months, oil and gas producers negotiate with banks how much credit they should be given, based on the value of their reserves in the ground.
Chesapeake, the No.2 U.S. natural gas producer, said on Monday that the next review of its borrowing base had been postponed until June 2017.
(Reporting by Anya George Tharakan in Bengaluru; Editing by Kirti Pandey)"
KTOV Shares - Market Cap
Shares Outstanding 3,806,828
Milestone Shares 68,953
Options (2013 Employee Plan) 11,644
Warrants (Series 2) 192,506
Warrants (August Loans) 86,000
ADS Warrants 3,378,974
Warrants issued to Underwriters 157,945
3.8 million shares x $5.30 per share = $20.14 million market cap currently
Fully diluted 7.7 million shares x $5.30 = $40 mil market cap currently
Current Portfolio Holdings 04/10
CERU 400sh @ $2.99 avg
CHMA 50sh @ $8.15 avg
KTOV 500sh @ $4.87 avg
ONTY 2000sh @ $1.20 avg
FCX Jan 20 2017 $20 calls 10 @ $0.21 avg
Will look to re-enter CHK, SWN, MRO this week on any dips
Watching CRC, PETX, REXX
May add more KTOV on weakness (like the odds on this one)
US Nat Gas Could Double
http://oilprice.com/Energy/Energy-General/Why-Natural-Gas-Prices-Could-Double-From-Here.html
Trade Alert ONTY
Purchased 2000sh @ $1.20
ASCO play - 1st week of June.
Trade Alert CHK
Sold 1000sh @ $3.70
Had an early move but could not hold gains.. Will look to enter again on a down oil/gas day...
Rig Count
"A year ago, 988 rigs were active.
Houston oilfield services company Baker Hughes Inc. said Friday 354 rigs sought oil and 89 explored for natural gas."
Oil/Nat Gas supply will drop = price will move up!!
Trade Alert SWN
Sold 500sh @ $8.46
Taking profits on the run in oil today...
Natural Gas US
I really like plays that are Oil and Nat Gas - I think Nat Gas is going to start moving as stockpiles get depleted and rig counts stay at historic lows. +/- 92 rigs running today from high of 1,600+ in 2008... It will take time to catch up as prices increase...
Top 5 US Nat Gas Producers
ExxonMobil
Chesapeake Energy
Anadarko
Southwestern Energy
Devon Energy
Crude Oil (+3.78%) Looking strong this morning. I may take profits on SWN and CHK going into weekend. Will watch to see how they trade today - good moves in pre trading...
Trying to be better about taking profits after TPIV cost me...
Trade Alert CHMA
Sold 50sh @ $10.50
I may hold remaining shares into FDA decision next week. Risk/Reward is high on both sides.
Trade Alert PGNX
Sold PGNX 300sh @ $4.53
Will buy again on a pull back
Trade Alert TPIV
Sold 2000sh @ $.68 for a small loss
Was looking for partnership news this week. I will look to enter again at a lower price.
First trade of 2016 that I was up over 15% (my target goal per trade) and I did not pull the trigger. A $200 mistake...
TPIV News
PR Newswire
"TapImmune, Inc. (TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, announced today it has successfully completed formulation development, scale-up, GMP (Good Manufacturing Practice) manufacturing, and the release of TPIV 200, its multi-epitope folate receptor peptide vaccine for breast and ovarian cancer. The manufactured product contains five peptide antigens freeze dried in a single vial, ready for injection after reconstitution and addition of granulocyte-macrophage colony-stimulating factor (GM-CSF). TPIV 200 doses are now available for the upcoming Phase II clinical trials in both triple negative breast cancer and ovarian cancer."
Portfolio Plays 04/05
CHMA 150sh @ $8.15
SWN 400sh @ $7.85
PGNX 300sh @ $4.11
CERU 400sh @ $2.99
KTOV 300sh @ $4.55
TPIV 2000sh @ $0.69
FCX Jan 2017 $20 Calls 10 @ $0.21
Trade Alert CHMA
Sold 50sh CHMA @ $10.80
Taking some more profit +30%
KTOV $4.55
Have been watching this one from the $3's but did not pull the trigger. I may take a small position soon 200-300sh....
Milestones Q1:
Complete CMC manufacturing
Pre-NDA meeting and FDA response
SWN $8.30
Watching for an entry in mid $7's
Big run yesterday on shady accounting with credit line. I guess I sold too early but I still made a good profit.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |